1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

21 Nov 2025
Admin
News Article

Pfizer and PRASHO Bring Migraine Awareness Workshops to Hyderabad Workplaces: A Push Toward Healthier, More Productive Teams

Migraine is not just a headache — and India’s corporate workforce is paying the price for misunderstanding it. To tackle one of the nation’s most overlooked productivity killers, the Pragyaan Sustainable Health Outcomes Foundation (PRASHO), in collaboration with Pfizer, has launched a series of migraine awareness and workplace productivity workshops across corporate organisations in Hyderabad.

These sessions aim to reshape workplace culture, educate employees, and drive early diagnosis of a neurological condition that silently drains India’s productivity every year.

Why Migraine Deserves Serious Workplace Attention?

A migraine episode disrupts focus, mood, and cognitive performance. According to a 2025 study published in The Journal of Headache and Pain, migraine is:

The 2nd leading cause of disability worldwide
The top cause of disability among women aged 15–49, the backbone of India’s workforce
Responsible for 3–4% loss of India’s annual productive time, mostly due to presenteeism — people working despite debilitating pain

Despite its scale, migraine is often shrugged off, misdiagnosed, or undertreated.

“Migraine is a significant public health issue that affects not just individuals but organisations and the economy at large.” — Prof G. V. S. Murthy, President, PRASHO

He emphasises that workplace awareness can help build empathetic, supportive environments that acknowledge the hidden burden of migraine.

What the Workshops Offer?

The workshops are being conducted by leading neurologists:

Dr Subhash Kaul, KIMS Hospitals
Dr Shyam Jaiswal, KIMS Hospitals
Dr G. V. Subbaiah Chowdhary, Yashoda Hospitals
Alongside Dr GVS Murthy and the PRASHO public-health team

Each session includes:

Interactive learning on migraine triggers and symptoms
Practical coping strategies
Guidance for adapting workplace environments
Anonymous employee surveys to help HR understand internal migraine burden

Insights from Medical Experts

Pfizer: Migraine Is an Economic Issue, Not Just a Medical One

“Migraine affects millions of working-age adults and results in over 17 lost workdays per person per year in India.”

— Dr Pankaj Gupta, Senior Director – Medical Affairs, Pfizer India

He highlights the need for early diagnosis and innovative support systems to build a more resilient workforce.

KIMS Hospitals: Young Employees Are Most Affected

“Migraine is common among younger professionals yet goes untreated, leading to avoidable productivity loss.”

— Dr Subhash Kaul, Senior Neurologist

Awareness programs help employees seek timely care, recognise early symptoms, and reduce the risk of severe episodes.

Yashoda Hospitals: It’s Time for a Cultural Shift

“Understanding migraines helps organisations build empathy and improve productivity.”

— Dr Subbaiah Chowdhary

KIMS Hospitals: Early Care Is Critical

“Migraine-related productivity loss is driven largely by presenteeism. Workplace interventions can make a measurable difference.”

— Dr Shyam Jaiswal

A Step Toward Healthier, More Inclusive Workplaces

By rolling out these workshops, PRASHO and Pfizer aim to transform Indian corporate environments into supportive, informed, and stigma-free spaces for people living with migraine.

Their message is clear: supporting brain health is essential for business health.

Let’s apply Data-Driven Pricing to Your APIs

Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.

Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.

Start using market intelligence today and allow yourself to be in control in the API market.

Check it out today and make more informed sourcing decisions! Learn More!